Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial
about
Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology.MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.
P2860
Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mailed HPV self-sampling for c ...... a randomized controlled trial
@en
Mailed HPV self-sampling for c ...... a randomized controlled trial.
@nl
type
label
Mailed HPV self-sampling for c ...... a randomized controlled trial
@en
Mailed HPV self-sampling for c ...... a randomized controlled trial.
@nl
prefLabel
Mailed HPV self-sampling for c ...... a randomized controlled trial
@en
Mailed HPV self-sampling for c ...... a randomized controlled trial.
@nl
P2093
P2860
P1433
P1476
Mailed HPV self-sampling for c ...... a randomized controlled trial
@en
P2093
Anthony Amofah
Dinah Trevil
Erin Kobetz
Jordan Baeker Bispo
Julia Seay
Larry Pierre
Martha Gonzalez
Martine Poitevien
Olveen Carrasquillo
Tulay Koru-Sengul
P2860
P2888
P356
10.1186/S13063-016-1721-6
P577
2017-01-13T00:00:00Z
P6179
1026892979